CD19 – Page 4 – Communicable Diseases Research

Immune Response after SARS-CoV-2 Vaccination in Kidney Transplant Patients

신장 이식 환자에서 SARS-CoV-2 백신 접종 후 면역 반응

Article

Published on 2021-12-032022-09-12
Journal: Medicina [Category] SARS, 진단,

Clinical impact of Ocrelizumab extended interval dosing during the COVID-19 pandemic and associations with CD19 + B-cell repopulation

COVID-19 대유행 기간 동안 Ocrelizumab 연장 간격 투여 및 CD19 + B 세포 재증식과의 연관성의 임상적 영향

Article

Published on 2021-11-012022-09-12
Journal: Multiple sclerosis and related disorders [Category] MERS, SARS, 진단,

[키워드] Abstract association B-cell CD19 clinical COVID-19 pandemic Extended Extended dosing extended interval Multiple multiple sclerosis Ocrelizumab
[DOI] 10.1016/j.msard.2021.103287 PMC 바로가기 [Article Type] Article

Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity

다양한 선천성 면역 오류가 있는 개인의 SARS-CoV-2 백신에 대한 항체 반응

Article

Published on 2021-11-012022-09-11
Journal: The Journal of Allergy and Clinical Immunology [Category] MERS, SARS, 진단, 치료법,

[키워드] adverse event adverse events affected age anti-S anti-S IgG anti-S IgG levels antibody Antibody Response Antibody titer Antibody titers Autoimmune B cells B-cell baseline candidiasis Care CD19 CD3 Cohort cohort of patient completion controls counseling COVID-19 COVID-19 vaccine Diagnosis dose evaluate Genetic Health Health care immune immune suppressants Immunity immunization immunization schedule immunized immunogenicity immunomodulators immunosuppressive drug immunosuppressive drugs Inborn errors inborn errors of immunity individual information Jak jak inhibitors janssen Johnson & Johnson less luciferase Luciferase immunoprecipitation system median medical records mRNA vaccine Patient patients plasma rate of seroconversion reported rituximab Safe SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination second dose Seroconversion single dose subsequent T cells the SARS-CoV-2 therapy These data thymoma Treatment Vaccinating Vaccine was collected were measured
[DOI] 10.1016/j.jaci.2021.08.016 PMC 바로가기 [Article Type] Article

COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes

Research Article

Published on 2021-10-182022-10-29
Journal: Journal of Immunology Research [Category] COVID-19, MERS, SARS,

[키워드] Acute inflammation affected analyzed ANOVA B cell B cells Cancer Cancer patients cancers carried CD16 CD19 CD3 CD4 CD56 CD8 changes in characteristic chi-square test clinical correlation Correlation analysis COVID-19 COVID-19 patient COVID-19 patients cytokine Cytokines diagnostic difference Diseases Effect identify IFN IL-10 IL-2 IL-4 IL-6 Immune cell immune disorder involved Lymphocyte subset lymphopenia Monocytes Neutrophils NK cell no significant difference objective outcomes parameter Patient patients with COVID-19 Result Retrospective study ROC severe COVID-19 patient significant difference Stage subgroup analysis subset T cell T cells TNF- α two subgroups variable were measured with COVID-19
[DOI] 10.1155/2021/8669098 PMC 바로가기 [Article Type] Research Article

Genetic and phenotypic analysis of the causal relationship between aging and COVID-19

Research

Published on 2021-10-052022-10-05
Journal: Communications Medicine [Category] 유전자 메커니즘, 임상, 치료법,

Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies

질병 수정 요법에 대한 다발성 경화증 환자의 COVID mRNA 백신에 대한 체액 반응의 특성화

Article

Published on 2021-10-012022-09-11
Journal: Vaccine [Category] SARS, 치료법,

[키워드] Absolute lymphocyte count ALC Anti-spike Antibody Response Autoimmune B cell B-cell baseline BMI body mass body mass index CD19 CD20 Cell Central nervous system characterization conducted COVID COVID-19 COVID-19 mRNA Vaccination COVID-19 vaccine cytometry analysis demonstrated demyelinating Demyelinating diseases depleting disease Diseases feature Flow cytometry analysis group healthy controls humoral humoral immune response Humoral response humoral responses Hypothesis identify IgM immune responses Immune Therapies immunological lymphocyte mRNA vaccination mRNA vaccine Multiple multiple sclerosis Neuromyelitis Optica not differ participant Patient positive antibody response Post-vaccine pre-vaccination Prospective Study RBD sclerosis single center tested therapy total treatment duration vaccine dose vaccine-induced antibody response
[DOI] 10.1016/j.vaccine.2021.08.078 PMC 바로가기 [Article Type] Article

SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity

리툭시맙 치료 환자에서 SARS-CoV-2 백신 접종: T 세포 매개 면역이 있는 경우 B 세포가 체액성 면역 반응을 촉진합니다

Article

Published on 2021-10-012022-09-11
Journal: Annals of the rheumatic diseases [Category] MERS, SARS, 진단, 치료기술,

[키워드] Affect antibody assays B cell B cells BNT162b2 CD19 controls correlated COVID-19 detectable develop Elecsy enzyme enzyme-linked immunosorbent except for healthy control healthy individual healthy individuals humoral humoral immune response humoral immune responses IFN-γ immune response immune responses immunisation immunoassay independent independent of induce levels of antibody mounted mRNA mRNA-1273 n=36 neutralisation neutralisation tests Neutralising Antibodies neutralising antibody one patient Patient patients peripheral B cell peripheral B cells promote protective effect Protective effects quantified RBD Receptor-binding domain responses rituximab RTX SARS-CoV-2 SARS-CoV-2 RBD SARS-CoV-2 vaccination SARS-CoV-2-specific antibodies SARS-CoV-2-specific antibody SARS-CoV-2-specific T cell SARS-CoV-2-specific T cells SARS-CoV-2-specific T-cell response SARS-CoV-2-specific T-cell responses seroconverted significantly specific antibodies Spike protein T cells T-cell responses T-cell-mediated immunity the patient the receptor-binding domain the SARS-CoV-2 the spike protein therapy Treatment vaccination
[DOI] 10.1136/annrheumdis-2021-220781 PMC 바로가기 [Article Type] Article

SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism

SARS-COV-2 감염은 B- 세포 대사를 강화함으로써 B 세포에서 CD19 발현을 하향 조절함으로써 회수 된 환자에서 면역 결핍을 유발한다.

Article

Published on 2021-09-222022-08-31
Journal: Signal Transduction and Targeted Therapy [Category] Fulltext, SARS, 바이오마커, 진단,

Immunological Analysis of People in Northeast China after SARS-CoV-2 Inactivated Vaccine Injection

Article

Published on 2021-09-162022-10-28
Journal: Vaccines [Category] COVID-19,

Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant Recipients

Oncology

Published on 2021-09-062022-10-31
Journal: Frontiers in Oncology [Category] COVID-19,

[키워드] administration Against Allogeneic allogeneic HSCT Antibody Response Antibody titer autologous autologous HSCT B cell B lymphocyte BNT162b2 CD19 CD19+ CD20 CD56+ Cell control group correlated correlation COVID-19 immunity cyclosporine Cytometry develop Efficacy evaluate Flow glycoprotein healthy subjects HSCT HSCT recipients immune response immunosuppressive Impaired mRNA-based natural killer negatively affected NK cell NK cells Patient performed Peripheral blood Pfizer-BioNTech platform Prospective Study recipient response rituximab SARS-CoV-2 IgG SARS-CoV-2 vaccine SARS-CoV2 second dose Seroconversion serum sample STEM Stem cell transplantation submitted T cells tested the antibody response the Spike Transplant vaccination Vaccine
[DOI] 10.3389/fonc.2021.737300 PMC 바로가기 [Article Type] Oncology